Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
online vegas casino games
Popular Articles

UK's NICE Recommends Use Of Erbitux For Metastatic Colorectal Cancer Patients
The United Kingdom"s National Institute for Health and Clinical Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending the use of the drug Erbitux® (cetuximab) in combination with chemotherapy as a 1st-line treatment for patients with metastatic (advanced) colorectal cancer (mCRC) who have met specific additional criteria1 - presenting the possibility of potentially curative surgery.2 The treatment is recommended for patients in whom the cancer has spread only to the liver and who have normal or "wild-type" KRAS tumors.1 In the UK, a recommendation by NICE is a prerequisite for funding of a medical treatment by the National Health Service.
drugs without prescription gocasino.com online casino
House Bill May Target Drugmakers' Advertising Tax Breaks
Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker"s advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, "one thing that"s not off the table is you can pick up $37 billion knocking out the deduction for advertising" for prescription drugs,"" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).
News of the day
Vets Say Badger Culling Is Necessary To Tackle TB
Badger culling is necessary in certain circumstances to tackle the spread of bovine tuberculosis (bTB), according to the British Veterinary Association (BVA) and British Cattle Veterinary Association (BCVA).
Health Insurance

Comparative Effectiveness Research Recommendations

Statement by APTA President R. Scott Ward, PT, PhD On Tuesday, June 30, the Institute of Medicine (IOM) and the Federal Coordinating Council for Comparative Effectiveness Research released their recommendations on comparative effectiveness research priorities that should be funded by the $1.1 billion made available under the American Recovery and Reinvestment Act (ARRA). I am pleased to report that many of the priorities outlined by IOM and the council include research that will draw conclusions about physical therapy intervention as compared with pharmaceutical and medical management. The IOM has recommended that comparative effectiveness research evaluate the effectiveness of prevention methods (exercise and balance) vs clinical treatments for falls risk; treatment strategies for low back pain; school based interventions, including physical education, on childhood obesity; long term effectiveness of weight bearing exercise and bisphosphonates on osteoporosis; treatment strategies, including physical therapy, on cervical disc and neck pain; and various quality improvement strategies on rehabilitation services for diverse populations. The council"s report cites the need for studies to "investigate the comparative effectiveness of rehabilitation interventions to restore or maintain functioning or minimize its loss," including physical therapy interventions. APTA is carefully reviewing the reports and will provide members in the coming days with a detailed summary of the recommendations. We expect to find that APTA"s priorities , which were outlined to the council in April, have been considered in the council"s report to Congress. As we stated to the council earlier this year, "Comparative effectiveness research will contribute to a high quality health care delivery system and improve the health of the nation." It is our hope that the funds provided in ARRA will go toward research that results in optimal care to those patients we serve. APTA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009